±í¹ÛÓÍË®·ÖÅäϵÊý,apparent oil/water partition coefficientÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÕ±¾´ó¶ú°×ÍÃ,Japanese white rabbitÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »ÇÜÐÎ÷ÁÖÄÆ,Sulbenicillin sodiumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ôȼ׻ùħÓó½º,carboxymethyl konjac glucomannanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·úÂÈÎ÷ÁÖÄÆ,flucloxacillin sodiumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½Ìѧ̽Ë÷,Teaching explorationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »ºÊÍĤ,slow-release membraneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °¢ÆæÃ¹ËؽºÄÒ,azithromycin capsuleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶þ¼×»ù°±ÂÈßÁßä,Dimethyl amilorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« KBϸ°û,KB cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϸ°ûÉ«ËØP4503A,CYP3AÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·¨ÄªÌæ¶¡×¢ÉäÒº,Famotidine InjectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò©Æ·Êг¡,Pharmaceutical marketÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¹Õæ¾úÒ©ÎïÃô¸ÐÐÔÊÔÑé,antifungal susceptibility testingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ҽԺҩѧÐÅϢϵͳ,hospital pharmacy information systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ͬÐͰëë×°±ËáÁòÄÚõ¥,Homocysteine thiolactoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« MTT·ÖÎö·¨,MTT assayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò©Îï¶¾Àíѧ,Drug ToxicologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÎËáÄÉÃÀ·Ò,nalmefene hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÀÒ°±ËáøÒÖÖÆ¼Á,tyrosinase inhibitorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Ê²ÝËáµ¥ï§,monoammonium glycyrrhizinateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´×ËáÀà,Acetic acidsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¹¹ýÃôÒ©,Antiallergic drugsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·¢ÏÖ¶¾Àíѧ,discovery toxicologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎüÊÕËٶȳ£Êý,absorption rate constantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Э×÷±ê¶¨,collaborative studyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µç×ÓÒ©Àú,Electronic medication recordÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚÔàÍ´¾õ¹ýÃô,visceral hyperalgesiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢¿×ÉøÍ¸±Ã,micro-porous osmotic pumpÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁòËáÎ÷Ë÷Ã×ÐÇ,sisomicin sulfateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿çĤתÔË,transmembrane transportÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏõËáë¹ûÜ¿Ïã¼î,Pilocarpine nitrateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¥Ïò¶¯×÷µçλ,Monophasic action potentialÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÎËá°¢ÆËÂð·È,apomorphine hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« SAS³ÌÐò,SAS programÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ßɰ±ÍÐÃÀÍ¡,amtolmetin guacylÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« N-Vµ°°×ø,N-V proteinaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« À×ÄÎËáïÈ,strontium ranelateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×é°·ÊÜÌå,Histamine receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÓñȪÍè,Yuquan PillÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÇÌú»¯ºÏÎï,ferrous compoundsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏÞÁ¿¼ì²é,limit testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϸ°ûÉ«ËØP4502C9,cytochrome P450 2C9Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÎËá¼ÓÌæÉ³ÐÇ,Gatifloxacin hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏûºÄ½ð¶î,consumptive amount of moneyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á×Ëá¸ÆË®Äà,Calcium phosphate cementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶àëÄ¿¹ÉúËØ,peptide antibioticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ú¼Ò»ù±¾Ò©ÎïÕþ²ß,National essential drug policyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¹ÌÇÄò²¡»îÐÔ,antidiabetic activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Èýάԭ×Ó³¡È«Ï¢×÷ÓÃʸÁ¿,three-dimensional holographic vector of atomic interaction field(3D-HoVAIF)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÄѪ¹Ü¶¾ÐÔ,cardiovascular toxicityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚõ¥ÐÍ,lactone formÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¦Â½ÚÂÉ,beta rhythmÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒæÉú×¢ÉäÒº,Yisheng injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶¯Ì¬±È×Ç·¨,kinetic turbidimetric assayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´«µÝϵͳ,delivery systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« c-mycÔ­°©»ùÒò,c-myc oncogeneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ȱ¸Æ,calcium deficiencyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¨ËáÀà,Cholic acidsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¹°¬×̲¡¶¾»îÐÔ,anti-HIV activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏàËÆÒò×Ó·¨,similarity factor methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌåÍâ¿¹Õæ¾ú»îÐÔ,in vitro antifungal activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×¢²á¹ÜÀí,registration managementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« TNF-¦ÁmRNA,TNF-¦Á mRNAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌåÍâÒ©ÎïÊÍ·Å,Drug release in vitroÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò©Æ·µ÷¼Á,Drug dispensingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µç»¯Ñ§¼ì²â·¨,electrochemical detectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÜѪ¶È,hemolytic degreeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϸ°ûÉ«ËØb5,Cytochrome b5Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Æ»ùÒòÏà¹ØëÄ,Calcitonin gene-related peptideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÎËáà­ÄÇÆÕÀû,quinapril hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉøÍ¸±Ã¿ØÊÍÆ¬,osmotic pump controlled release tabletsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ä£Ðͺ¯Êý,Model functionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« P-Ìǵ°°×ÒÖÖÆ¼Á,P-glycoprotein inhibitorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« XaÒò×Ó,Factor XaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒâʶÏûʧ,Loss of consciousnessÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÛÍ´Ä£ÐÍ,pain modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ç⻯¿ÉµÄËÉ×¢ÉäÒº,Hydrocortisone injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¦Æ½»¬¼¡,intestinal smooth muscleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿ØÊÍϵͳ,controlled release systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºìÃ¹ËØ»·11,12-̼Ëáõ¥,Erythromycin cyclic 11,12-carbonateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ßÉÂØËáÄÆ,sodium gualenateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´¿¿¹´Æ¼¤ËØ,Pure antiestrogenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿Úǻճ¸½Æ¬,Buccal adhesive tabletÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« TTC·¨,TTC methodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏßÐÔ¶¯Ì¬·¶Î§,Linear dynamic rangeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³É±¾Ô¼Êø,cost constraintÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±ÕÈûЧӦ,plugging effectÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò©Îﰲȫ,drug safetyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½ºÊøµç¶¯Ã«Ï¸¹ÜµçÓ¾,micellar electrokinetic capillary chromatographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹âÏË´«¸Ðϵͳ,optical fiber sensing systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÖÂÛ·¨,Discussion MethodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÞÖ¸Å̳ôÍÜ,Odorrana grahamiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »¯Ñ§Ô¤·À¼Á,chemopreventive agentsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÛ»¯µã,melting pointÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¹Çò³æ»îÐÔ,anticoccidial activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ËáÐÔ½µ½â,acid degradationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÞ¾ú¼ì²é·¨,sterility testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔÖº¦Ê¼þ,disaster eventÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÅÏ¢¼ìË÷ÓëÀûÓÃ,information retrieval and utilizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«